Tandem Diabetes Care, Inc. Operating Cash Flow
Tandem Diabetes Care, Inc. (TNDM) reported Operating Cash Flow of -$23.58 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- Tandem Diabetes Care, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$34.63M.
- Tandem Diabetes Care, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $11.05M.
- Tandem Diabetes Care, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $9.79M, a 8.66% decline year-over-year.
- Tandem Diabetes Care, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $8.26M, a 69.14% decline year-over-year.
- Tandem Diabetes Care, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$9.72M, a 140.13% decline from fiscal 2024.
- Tandem Diabetes Care, Inc. net cash provided by (used in) operating activities for fiscal 2024 was $24.23M.
- Tandem Diabetes Care, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$31.81M, a 163.04% decline from fiscal 2022.
- Tandem Diabetes Care, Inc. net cash provided by (used in) operating activities for fiscal 2022 was $50.46M, a 54.68% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$34.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$23.58M 10-Q · filed 2026-08-06 | -$13.79M derived: sum of 3 quarters · filed 2026-08-06 | -$5.52M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $11.05M 10-Q · filed 2026-05-07 | $20.84M derived: sum of 2 quarters · filed 2026-05-07 | $29.11M derived: sum of 3 quarters · filed 2026-05-07 | $19.61M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $9.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $18.05M derived: sum of 2 quarters · filed 2026-02-19 | $8.56M derived: sum of 3 quarters · filed 2026-08-06 | -$9.72M 10-K · filed 2026-02-19 | |
| 2025-09-30 | $8.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.23M derived: sum of 2 quarters · filed 2026-08-06 | -$19.51M 10-Q · filed 2025-11-06 | -$8.79M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | -$9.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$27.77M 10-Q · filed 2026-08-06 | -$17.06M derived: sum of 3 quarters · filed 2026-08-06 | $9.72M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | -$18.28M 10-Q · filed 2026-05-07 | -$7.56M derived: sum of 2 quarters · filed 2026-05-07 | $19.22M derived: sum of 3 quarters · filed 2026-05-07 | $13.94M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $10.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $37.50M derived: sum of 2 quarters · filed 2026-02-19 | $32.22M derived: sum of 3 quarters · filed 2026-02-19 | $24.23M 10-K · filed 2026-02-19 | |
| 2024-09-30 | $26.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $21.50M derived: sum of 2 quarters · filed 2025-11-06 | $13.51M 10-Q · filed 2025-11-06 | $6.29M derived: sum of 4 quarters · filed 2026-02-19 | |
| 2024-06-30 | -$5.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$13.27M 10-Q · filed 2025-08-06 | -$20.49M derived: sum of 3 quarters · filed 2026-02-19 | -$20.43M derived: sum of 4 quarters · filed 2026-02-19 | |
| 2024-03-31 | -$8.00M 10-Q · filed 2025-04-30 | -$15.21M derived: sum of 2 quarters · filed 2026-02-19 | -$15.16M derived: sum of 3 quarters · filed 2026-02-19 | -$21.48M derived: sum of 4 quarters · filed 2026-02-19 | |
| 2023-12-31 | -$7.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$7.16M derived: sum of 2 quarters · filed 2026-02-19 | -$13.48M derived: sum of 3 quarters · filed 2026-02-19 | -$31.81M 10-K · filed 2026-02-19 | |
| 2023-09-30 | $55.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$6.27M derived: sum of 2 quarters · filed 2024-11-06 | -$24.59M 10-Q · filed 2024-11-06 | -$18.77M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-06-30 | -$6.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$24.65M 10-Q · filed 2024-08-01 | -$18.83M derived: sum of 3 quarters · filed 2025-02-26 | $5.11M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-03-31 | -$18.33M 10-Q · filed 2024-05-02 | -$12.51M derived: sum of 2 quarters · filed 2025-02-26 | $11.44M derived: sum of 3 quarters · filed 2025-02-26 | $18.34M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2022-12-31 | $5.82M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $29.76M derived: sum of 2 quarters · filed 2025-02-26 | $36.66M derived: sum of 3 quarters · filed 2025-02-26 | $50.46M 10-K · filed 2025-02-26 | |
| 2022-09-30 | $23.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $30.84M derived: sum of 2 quarters · filed 2023-11-01 | $44.64M 10-Q · filed 2023-11-01 | $64.28M derived: sum of 4 quarters · filed 2024-02-21 | |
| 2022-06-30 | $6.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $20.70M 10-Q · filed 2023-08-03 | $40.34M derived: sum of 3 quarters · filed 2024-02-21 | $74.48M derived: sum of 4 quarters · filed 2024-02-21 | |
| 2022-03-31 | $13.80M 10-Q · filed 2023-05-03 | $33.44M derived: sum of 2 quarters · filed 2024-02-21 | $67.58M derived: sum of 3 quarters · filed 2024-02-21 | $96.47M derived: sum of 4 quarters · filed 2024-02-21 | |
| 2021-12-31 | $19.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $53.78M derived: sum of 2 quarters · filed 2024-02-21 | $82.67M derived: sum of 3 quarters · filed 2024-02-21 | $111.36M 10-K · filed 2024-02-21 | |
| 2021-09-30 | $34.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $63.04M derived: sum of 2 quarters · filed 2022-11-02 | $91.72M 10-Q · filed 2022-11-02 | $106.96M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2021-06-30 | $28.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $57.58M 10-Q · filed 2022-08-03 | $72.82M derived: sum of 3 quarters · filed 2023-02-22 | $87.38M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2021-03-31 | $28.68M 10-Q · filed 2022-05-04 | $43.92M derived: sum of 2 quarters · filed 2023-02-22 | $58.49M derived: sum of 3 quarters · filed 2023-02-22 | $73.98M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2020-12-31 | $15.24M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $29.80M derived: sum of 2 quarters · filed 2023-02-22 | $45.30M derived: sum of 3 quarters · filed 2023-02-22 | $24.67M 10-K · filed 2023-02-22 | |
| 2020-09-30 | $14.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $30.06M derived: sum of 2 quarters · filed 2021-11-03 | $9.43M 10-Q · filed 2021-11-03 | $28.88M derived: sum of 4 quarters · filed 2022-02-22 | |
| 2020-06-30 | $15.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$5.13M 10-Q · filed 2021-08-04 | $14.31M derived: sum of 3 quarters · filed 2022-02-22 | $37.33M derived: sum of 4 quarters · filed 2022-02-22 | |
| 2020-03-31 | -$20.63M 10-Q · filed 2021-05-05 | -$1.19M derived: sum of 2 quarters · filed 2022-02-22 | $21.83M derived: sum of 3 quarters · filed 2022-02-22 | $25.40M derived: sum of 4 quarters · filed 2022-02-22 | |
| 2019-12-31 | $19.44M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $42.46M derived: sum of 2 quarters · filed 2022-02-22 | $46.03M derived: sum of 3 quarters · filed 2022-02-22 | $41.91M 10-K · filed 2022-02-22 | $41.91M 10-K · filed 2020-02-24 |
| 2019-09-30 | $23.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $26.59M derived: sum of 2 quarters · filed 2020-11-05 | $22.46M 10-Q · filed 2020-11-05 | $36.60M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-06-30 | $3.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$556.00K 10-Q · filed 2020-07-30 | $13.58M derived: sum of 3 quarters · filed 2021-02-24 | $10.12M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-03-31 | -$4.12M 10-Q · filed 2020-04-30 | $10.01M derived: sum of 2 quarters · filed 2021-02-24 | $6.55M derived: sum of 3 quarters · filed 2021-02-24 | -$171.00K derived: sum of 4 quarters · filed 2021-02-24 | |
| 2018-12-31 | $14.13M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $10.68M derived: sum of 2 quarters · filed 2021-02-24 | $3.95M derived: sum of 3 quarters · filed 2021-02-24 | -$8.32M 10-K · filed 2021-02-24 | |
| 2018-09-30 | -$3.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | -$10.18M derived: sum of 2 quarters · filed 2019-11-04 | -$22.45M 10-Q · filed 2019-11-04 | -$34.09M derived: sum of 4 quarters · filed 2020-02-24 | |
| 2018-06-30 | -$6.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$19.00M 10-Q · filed 2019-08-01 | -$30.64M derived: sum of 3 quarters · filed 2020-02-24 | -$49.65M derived: sum of 4 quarters · filed 2020-02-24 | |
| 2018-03-31 | -$12.27M 10-Q · filed 2019-04-30 | -$23.91M derived: sum of 2 quarters · filed 2020-02-24 | -$42.93M derived: sum of 3 quarters · filed 2020-02-24 | ||
| 2017-12-31 | -$11.64M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | -$30.66M derived: sum of 2 quarters · filed 2020-02-24 | -$66.14M 10-K · filed 2020-02-24 | ||
| 2017-09-30 | -$19.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$54.49M 10-Q · filed 2018-11-01 | |||
| 2017-06-30 | -$35.48M 10-Q · filed 2018-07-30 | ||||
| 2016-12-31 | -$61.17M 10-K · filed 2019-02-26 | ||||
| 2014-03-31 | -$16.96M 10-Q · filed 2014-05-06 | ||||
| 2013-03-31 | -$8.81M 10-Q · filed 2014-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |